Arcadia Biosciences, Inc. (RKDA) › Operating IncomeArcadia Biosciences, Inc. (RKDA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$15.15M2015: -$15.56M2016: -$18.62M2017: -$14.31M2018: -$16.87M2019: -$19.38M2020: -$12.78M2021: -$35.53M2022: -$14.01M2023: -$6.10M2024: -$3.65M2025: -$2.50M-$2.50M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.50M+31.5%2024-$3.65M+40.2%2023-$6.10M+56.4%2022-$14.01M+60.6%2021-$35.53M-178.0%2020-$12.78M+34.1%2019-$19.38M-14.9%2018-$16.87M-17.8%2017-$14.31M+23.1%2016-$18.62M-19.6%2015-$15.56M-2.7%2014-$15.15M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share